Three-Year Real-World Study Compares Burosumab Treatment with Oral Phosphate and Active Vitamin D in Adults with XLH

Three-year real-world study compares treatment outcomes in adults with XLH, including serum phosphate, pain, stiffness, and physical function.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.